The acronym nonalcoholic fatty-liver disease (NAFLD) groups a heterogeneous patient
population. Although in many patients the primary driver is metabolic dysfunction, a complex …

Obesity is a major public health issue worldwide since it is associated with the development
of chronic comorbidities such as type 2 diabetes, dyslipidemias, atherosclerosis, some …

The study of psoriasis has yielded fundamental new insights into immunologic regulation
and innovative therapies in a way that few other diseases have. In this review, we …

Nonalcoholic fatty liver disease (NAFLD) is becoming a frequent liver disease, especially in
patients with metabolic syndrome and especially in Western countries. Complications of …

Background Association between nonalcoholic fatty liver disease (NAFLD) and future
psoriasis has not yet been confirmed, although the two diseases partially share a common …

There is increasing interest in the association between psoriasis and non-alcoholic fatty liver
disease (NAFLD), which is a prevalent liver disease characterized by excessive fat storage …

Liver disease is one of the most important causes of morbidity and mortality worldwide
whose prevalence is dramatically increasing. The first sign of hepatic damage is …

Aim: There are no studies regarding comparative analysis of serum biomarkers of oxidative
stress in patients with psoriasis (PsO) and atopic dermatitis (AD). We aimed to compare the …

Non-alcoholic fatty liver disease (NAFLD) is characterized by the excessive and detrimental
accumulation of liver fat as a result of high-caloric intake and/or cellular and molecular …

The liver, as a central metabolic organ, is systemically linked to metabolic–inflammatory
diseases. In the pathogenesis of the metabolic syndrome, inflammatory and metabolic …